Joseph Vazzano
CFO
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Avenue Therapeutics, Inc. (ATXI) | Former Chief Financial Officer | $20,514 | $21,335 |
| 2021 | Avenue Therapeutics, Inc. (ATXI) | Former Chief Financial Officer | $255,747 | $441,325 |
| 2020 | Avenue Therapeutics, Inc. (ATXI) | Chief Financial Officer | $206,000 | $214,890 |
| 2019 | Avenue Therapeutics, Inc. (ATXI) | Chief Financial Officer | $198,113 | $258,779 |
| 2018 | Avenue Therapeutics, Inc. (ATXI) | Chief Financial Officer | $175,100 | $354,528 |
Executive changes
Earnings-call appearances
-
Abeona Therapeutics Inc. Q1 FY2026 Earnings Call2026-05-13
Abeona Therapeutics Inc. (ABEO)
-
Abeona Therapeutics Inc. Q3 FY2023 Earnings Call2023-11-13
Abeona Therapeutics Inc. (ABEO)
-
Abeona Therapeutics Inc. Q2 FY2022 Earnings Call2022-08-11
Abeona Therapeutics Inc. (ABEO)
-
Abeona Therapeutics Inc. Q1 FY2022 Earnings Call2022-05-13
Abeona Therapeutics Inc. (ABEO)